DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mozobil (Plerixafor Subcutaneous) - Respiratory Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Respiratory Failure (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) where reactions include respiratory failure. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 108.0 kg (237.6 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: female, weighing 85.9 kg (189.0 pounds)

Reactions: White Blood Cell Count Decreased, Acute Myeloid Leukaemia, Pulmonary Alveolar Haemorrhage, Febrile Neutropenia, Lung Infection Pseudomonal, Pseudomonal Bacteraemia, Multi-Organ Failure, Respiratory Failure, Platelet Count Decreased, Cardiac Arrest, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Neupogen; Carvedilol; Cefpodoxime Proxetil; Polyethylene Glycol; Valacyclovir Hydrochloride; Furosemide; Fluconazole; Temazepam; Fluticasone W; Tramadol HCL; Lansoprazole; Nifedipine; Nifedipine; Docusate Sodium W; Ondansetron Hydrochloride; Potassium Chloride; Levothyroxine Sodium; Sorafenib; Heparin; Lisinopril



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-07-16

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-03-20

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Respiratory Failure, Sepsis, Haemorrhage Intracranial

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Platelets; Neupogen



Possible Mozobil side effects in male

Reported by a physician from United States on 2012-03-02

Patient: male, weighing 80.1 kg (176.2 pounds)

Reactions: Productive Cough, Tachycardia, Clostridium Difficile Colitis, Pyrexia, Lactic Acidosis, Muscle Haemorrhage, Post-Traumatic Pain, Dyspepsia, Oedema Peripheral, Pulmonary Oedema, Hypoxia, Back Pain, Phlebitis, Pneumonia, Pain in Extremity, Hypoaesthesia, Delirium, Insomnia, Rash Erythematous, Streptococcal Bacteraemia, Chills, Mental Status Changes, Constipation, Generalised Oedema, Hepatomegaly, Pleural Effusion, Dizziness, Tachypnoea, Depression, Hallucination, Nausea, Acquired Diaphragmatic Eventration, Arthralgia, Respiratory Failure, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Indication: Haematopoietic Stem Cell Mobilisation

Mozobil
    Dosage: 46.6 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-09-02
    End date: 2011-10-08

Other drugs received by patient: Acetaminophen; Loperamide HCL; Rosuvastatin; Isosorbide Mononitrate; Metoprolol Succinate; Lorazepam; Meropenem; Gastrografin; Acetaminophen; Phytonadione; Magnesium Sulfate; Magnesium Sulfate; Cefepime; Ranexa; Furosemide; Furosemide; Allopurinol; Metoprolol Succinate; Vancomycin; Hydromorphone HCL; Furosemide; Ramipril; Metoprolol Succinate; Digoxin; Metronidazole; Acetaminophen; Phytonadione; Magnesium Sulfate; Albuterol; Diphenhydramine HCL; Heparin Lock-Flush; Vancomycin; Hydromorphone HCL; Potassium Chloride; Potassium Chloride; Potassium Chloride; Acetylcysteine; Multi-Vitamin; Metronidazole; Ipratropium Bromide; Sodium Chloride; Hydrocortisone; Decitabine; Phytonadione; Ipratropium Bromide; Albuterol; Albuterol; Ranexa; Furosemide; Allopurinol; Isosorbide Mononitrate; Metoprolol Succinate; Voriconazole; Potassium Chloride; Piperacillin W; Acetaminophen; Furosemide; Lidocaine; Metoprolol Succinate; Diphenhydramine HCL; Vancomycin; Biotene; Metronidazole; Cefepime; Furosemide; Potassium Chloride; Potassium Chloride; Digoxin; Digoxin



Possible Mozobil side effects in female

Reported by a physician from Korea, Republic of on 2012-01-27

Patient: female, weighing 22.2 kg (48.8 pounds)

Reactions: Respiratory Failure, Interstitial Lung Disease, Respiratory Arrest, Influenza A Virus Test Positive

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil
    Indication: Medulloblastoma

Mozobil
    Dosage: 6.5 mg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2010-10-24
    End date: 2010-10-25

Other drugs received by patient: Acyclovir; Neupogen; Deferoxamine Mesylate; Ambroxol; Cefditoren; Fenoterol; Sulfamethoxazole W



Possible Mozobil side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-14

Patient: male

Reactions: Multi-Organ Failure, Respiratory Failure, Pseudomonal Sepsis, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: unk
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-01
    End date: 2011-01-01

Mozobil
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Decitabine



Possible Mozobil side effects in male

Reported by a physician from United States on 2011-11-15

Patient: male, weighing 80.1 kg (176.2 pounds)

Reactions: Productive Cough, Tachycardia, Clostridium Difficile Colitis, Lactic Acidosis, Pyrexia, Muscle Haemorrhage, Dyspepsia, Post-Traumatic Pain, Oedema Peripheral, Hypoxia, Pulmonary Oedema, Phlebitis, Back Pain, Pneumonia, Pain in Extremity, Hypoaesthesia, Delirium, Rash Erythematous, Insomnia, Streptococcal Bacteraemia, Chills, Mental Status Changes, Constipation, Generalised Oedema, Hepatomegaly, Pleural Effusion, Dizziness, Tachypnoea, Depression, Hallucination, Nausea, Arthralgia, Acquired Diaphragmatic Eventration, Respiratory Failure, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Indication: Haematopoietic Stem Cell Mobilisation

Mozobil
    Dosage: 46.6 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-09-02
    End date: 2011-10-08

Other drugs received by patient: Acetaminophen; Cefepime; Furosemide; Lorazepam; Decitabine; Albuterol; Furosemide; Allopurinol; Metoprolol Succinate; Hydromorphone HCL; Potassium Chloride; Potassium Chloride; Potassium Chloride; Potassium Chloride; Acetylcysteine; Multi-Vitamin; Metronidazole; Acetaminophen; Acetaminophen; Furosemide; Furosemide; Allopurinol; Lidocaine; Hydrocortisone; Diphenhydramine HCL; Heparin Lock-Flush; Vancomycin; Biotene; Metronidazole; Albuterol; Furosemide; Ramipril; Magnesium Sulfate; Magnesium Sulfate; Ipratropium Bromide; Albuterol; Ranexa; Isosorbide Mononitrate; Diphenhydramine HCL; Vancomycin; Digoxin; Piperacillin W; Metronidazole; Phytonadione; Phytonadione; Loperamide HCL; Metoprolol Succinate; Vancomycin; Posaconazole; Potassium Chloride; Acetaminophen; Ipratropium Bromide; Cefepime; Ranexa; Sodium Chloride; Rosuvastatin; Isosorbide Mononitrate; Metoprolol Succinate; Digoxin; Digoxin; Gastrografin; Phytonadione; Magnesium Sulfate; Furosemide; Metoprolol Succinate; Metoprolol Succinate; Hydromorphone HCL; Potassium Chloride; Meropenem



Possible Mozobil side effects in male

Reported by a physician from United States on 2011-10-28

Patient: male

Reactions: Multi-Organ Failure, Respiratory Failure, Pseudomonal Sepsis, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: unk
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-01
    End date: 2011-01-01

Mozobil
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Decitabine



Possible Mozobil side effects in male

Reported by a consumer/non-health professional from United States on 2011-10-28

Patient: male

Reactions: Multi-Organ Failure, Respiratory Failure, Pseudomonal Sepsis, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil
    Dosage: unk
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-01-01
    End date: 2011-01-01

Mozobil
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Decitabine



Possible Mozobil side effects in male

Reported by a physician from United States on 2011-10-24

Patient: male

Reactions: Muscle Haemorrhage, Pneumonia, Metabolic Acidosis, Diarrhoea, Respiratory Failure, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Decitabine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017